SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane…

Overview of attention for article published in Trials, August 2021

Altmetric Badge

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials

Article in Clinical Microbiology and Infection (February 2024)

Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Article in Trials (April 2022)

Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta indica (Indian Neem) Against Delta and Omicron Variants of SARS-CoV-2

Article in Coronaviruses (January 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.